Home
Novartis India Ltd Quarterly Result

Novartis India Ltd
NSE: NOVARTIND
Net Profit - Last Quarter
Novartis India Ltd Quarterly Results Key Highlights
- The revenue of Novartis India Ltd for the Dec '24 is ₹ 103.6 crore as compare to the Sep '24 revenue of ₹ 97.43 crore.
- This represent the growth of 6.33%a1# The ebitda of Novartis India Ltd for the Dec '24 is ₹ 36.18 crore as compare to the Sep '24 ebitda of ₹ 28.29 crore.
- This represent the growth of 27.89%a1# The net profit of Novartis India Ltd for the Dec '24 is ₹ 25.45 crore as compare to the Sep '24 net profit of ₹ 20.41 crore.
- This represent the growth of 24.69%a1#.
Novartis India Ltd Quarterly Results Analysis
Market Price of Novartis India Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 836 |
20 Feb 2025 | 836.1 |
19 Feb 2025 | 814.8 |
18 Feb 2025 | 804.45 |
17 Feb 2025 | 798.65 |
14 Feb 2025 | 802.65 |
13 Feb 2025 | 823.45 |
12 Feb 2025 | 849.2 |
11 Feb 2025 | 834.8 |
10 Feb 2025 | 850.35 |
Historical Revenue of Novartis India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Novartis India Ltd
Historical EBITDA of Novartis India Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Novartis India Ltd
Historical Net Profit of Novartis India Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Novartis India Ltd
Novartis India Ltd News Hub
Novartis India schedules board meeting
Novartis India will hold a meeting of the Board of Directors of the Company on 25 October 2024. Powe
Read more
28 Sept 24
Novartis India standalone net profit declines 13.81% in the September 2024 quarter
Net profit of Novartis India declined 13.81% to Rs 20.41 crore in the quarter ended September 2024 a
Read more
25 Oct 24
Novartis India to hold board meeting
Novartis India will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe
Read more
28 Dec 24
Novartis India standalone net profit declines 4.22% in the December 2024 quarter
Net profit of Novartis India declined 4.22% to Rs 25.45 crore in the quarter ended December 2024 as
Read more
28 Jan 25